Acquisition provides Pfizer with a preclinical CMV vaccine candidate Pfizer Inc.

Christian Schaub, CEO of Redbiotec and Managing Director of Redvax commented, ‘We are pleased to have finished this deal with Pfizer, a global leader in vaccines. This represents an important step toward the advancement of a essential vaccine for CMV, a disease which has a devastating effect on children and families. We believe that combining Redvax’s property with Pfizer’s commitment, knowledge and resources will considerably improve the potential of developing this essential vaccine.’ About Pfizer Inc.The Abbott board of directors has approved a fresh $5 billion share repurchase program. Last year, Abbott returned a lot more than $3 billion to shareholders through dividends and talk about repurchase, and is on track to exceed this known level in 2008. ‘All of Abbott’s companies are performing remarkably well, before expectations,’ said Kilometers D. Light, chairman and ceo, Abbott. ‘Abbott continues to be well-positioned, with strong core development franchises, including our emerging vascular business, which is normally rapidly becoming a significant contributor to Abbott’s growth.’ Abbott’s news releases and other details are available on the company’s Internet site at.

24 Million Americans Have Diabetes The number of Americans with diabetes is continuing to grow to about 24 million people, or roughly 8 % of the U.S.